<DOC>
	<DOCNO>NCT00691691</DOCNO>
	<brief_summary>Patients primary hepato-biliary malignancy liver metastases gastrointestinal cancer suffer substantial morbidity mortality hepatic disease . Curative resection feasible select subgroup patient . The majority patient unresectable incurable disease . Aggressive arterial systemic chemotherapy use recent year improve response survival . However , significant number patient , least one-third patient liver metastasis colorectal cancer two-third higher unresectable hepatobiliary cancer , continue die liver failure progressive disease liver . Percutaneous ethanol injection , chemoembolization , cryotherapy thermal ablation use radiofrequency use treat select patient small tumor ( 3-4 cm ) area away major blood vessel biliary tract . However , unresectable liver cancer fit criteria treatment . Therefore , regional therapeutic option like external radiation therapy may consider local control liver symptom palliation</brief_summary>
	<brief_title>Stereotactic Body Radiation Therapy ( SBRT ) Treatment Liver Tumors</brief_title>
	<detailed_description />
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Histologically conformation liver malignancy Solitary multiple liver tumor amenable SBRT No jaundice liver dysfunction For metastasis , primary tumor site adequately treat . For primary hepatoma , extrahepatic disease Karnofsky &gt; 70 extrahepatic disease Liver failure inadequate liver function Ascites Previous radiation therapy liver lesion invade major blood vessel porta region Contraindication receive radiation therapy liver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Liver malignancy</keyword>
	<keyword>Stereotactic Body Radiation Therapy</keyword>
	<keyword>Efficacy SBRT liver tumor</keyword>
	<keyword>Hepatic toxicity SBRT</keyword>
</DOC>